MTOR and mantle cell lymphoma: For example, in mantle cell lymphoma (MCL), PI3K and AKT, but not mammalian target of rapamycin (mTOR), inhibitors have been demonstrated to be able to cause significant reduction in leukaemic cell viability, which is again associated with FOXO3 nuclear translocation and activation [43].